Premium
SAFETY AND EFFICACY ANALYSIS OF ELDERLY PATIENTS TREATED WITHIN THE GATLA HL ‐05 CLINICAL TRIAL: PET ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF H ODGKIN LYMPHOMA
Author(s) -
Ciliberti E.,
Fernandez I.,
Kurgansky N.,
Prates V.,
Zoppegno L.,
Negri P.,
Milone G.,
Cerutti I.,
Zabaljauregui S.,
Mariano R.,
Fernandez Grecco H.,
Saba S.,
Sackmann F.,
Castano V.,
Remaggi G.,
Cabrejo M.,
Rudoy S.,
Roveri E.,
Cabane V.,
Gumpel C.,
Taus R.,
Casale M.,
Taus R.,
Sakamoto F.,
Pavlovsky A.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_26
Subject(s) - medicine , abvd , hazard ratio , population , clinical trial , survival analysis , oncology , chemotherapy , confidence interval , cyclophosphamide , environmental health , vincristine